
Aspiring scientist. Instructor in @mishabeltran's lab @DanaFarber. @PCF_Science Young Investigator. Tweets are mostly fictional :)
Boston, MA
Joined January 2009
- Tweets342
- Following678
- Followers468
- Likes2.3K
Balaji retweeted
Congratulations to Mary-Ellen Taplin, MD, recipient of the 2026 PCF Women in Science Lifetime Achievement Award.
She asked in 1995 why prostate cancer stops responding to hormone therapy, then spent decades turning that answer into standard care.
#PCFRetreat26
Grateful to have been selected to attend the πππ¨ππ£π ππ©ππ§π¨ ππ«ππ§ π©ππ ππ€ππ πππ¨ conference at @CUCancerCenter, bringing together K-awardees navigating the leap to independent research. Great insights, great people, great collaborations ahead.
Thrilled to share I've received the NIH/NCI K99/R00 Award!
Deeply grateful to my mentor @mishabeltran for her immense support, my advisory committee and referees, and to @PCF_Science and DoD for early funding that made this possible.
Big shoutout to Precious Onyeagoro (#WorkforceDevelopment) and Nehemiah Costello (#CURE), two outstanding students I had the pleasure of co-mentoring with @mishabeltran this summer in the #BeltranLab at @DanaFarber. Excited to see where your scientific journeys take you next.
Balaji retweeted
Congratulations to @Bajji on an NCI K99/R00 award for research in @mishabeltran's lab at @DanaFarber investigating the epigenetic drivers of treatment resistance in neuroendocrine prostate cancer, an aggressive disease with no approved targeted therapies. β‘οΈbit.ly/3TtYRp0
Excited to share our new πππ©πͺπ§π πΎπ€π’π’πͺπ£ππππ©ππ€π£π¨ paper (collab b/w the @mishabeltran and @RickmanLab labs) revealing how Polycomb and DNA methylation cooperate to drive lineage plasticity in #ProstateCancer. Co-led with @Richa2807Singh.
bit.ly/4svqBGn
Balaji retweeted
PROX1 explored as a driver of neuroendocrine #ProstateCancer progression. @Bajji @DanaFarber joins @AndreaMiyahira @PCFnews in discussing #PROX1 as an epigenetically derepressed driver in neuroendocrine prostate cancer. #WatchNow on UroToday > bit.ly/47kzVEk
Balaji retweeted
Excited to share our new paper @NatureComms in collaboration with @RickmanLab, led by #RichaSingh @WeillCornell and @Bajji @DanaFarber #BeltranLab
New research published in @NatureComms provides critical mechanistic insights into how prostate cancer becomes resistant to treatment, uncovering how two key epigenetic mechanisms - DNA methylation and EZH2 activity - work together to drive transformation to a more aggressive form of the disease, neuroendocrine prostate cancer. @DanaFarber @bajji @mishabeltran
Read more: bit.ly/4sk61bg
I was glad to join @AndreaMiyahira on the digital platform of @urotoday to discuss our recent publication inΒ πΎππ£πππ§ πππ¨πππ§ππΒ from the #BeltranLab on PROX1 as a driver of neuroendocrine prostate cancer progression.
tinyurl.com/48z839de
@mishabeltran @PCF_Science
Balaji retweeted
Just out today in @jclinicalinvest π
mHSPC is not one disease, but a kaleidoscope of biological states. We highlight what we know β and the key gaps that remain β on the road to precision medicineβ¨
Led by my mentor @mishabeltran π
#ProstateCancer #mHSPC #PrecisionOncology
Exploring the biology of metastatic hormone-sensitive #ProstateCancer: on the road to precision medicine
In this Review, Alice Bernard-Tessier & Himisha Beltran @mishabeltran @danafarber discuss the underlying biology in mHSPC and highlight current knowledge gaps: doi.org/10.1172/JCI200920
Grateful for the chance to present at the #AACRprostate26 last week and honored to receive a ππππ€π‘ππ§-ππ£-ππ§πππ£ππ£π πΌπ¬ππ§π.
I shared work from the #BeltranLab on epigenetic mechanisms of lineage plasticity in advanced prostate cancer.
Delighted to be invited to speak at the @DFCI_PGA Brain Lunch Seminar Series last week.
Presented our latest work from the @mishabeltran lab on epigenetic mechanisms of lineage plasticity in treatment-resistant prostate cancer.
Big thanks to the organizers for the invitation.
Balaji retweeted
Great lightening talks by Beltran Lab members Balaji and Jake presenting their latest work! #AACRProstate26 @DanaFarber_GU
A massive congratulations to two of our faculty members, Himisha Beltran (@mishabeltran) & Joaquim Bellmunt (@OncoBellmunt), who were promoted to Professor of Medicine at Harvard Medical School in December!
Many thanks to my mentor, @mishabeltran, for the opportunity to share the stage with my friend and colleague,@mkbakht, and present some of our latest unpublished work at the @DanaFarber Division of Molecular and Cellular Oncology Retreat 2025.
#BeltranLab
Congratulations Dr Alice Bernard-Tessier β¦@alicebernardtβ© for receiving a PCF YIA! #proudmentor #BeltranLab β¦@DanaFarber_GUβ© @GustaveRoussyβ© β¦@PCF_Scienceβ© β¦@DrChoueiriβ©
Futuristic therapy for prostate cancer.
The sad prostate cancer cell is bombarded with combinatorial therapies.
#PCFYI
#PCFRetreat25 @PCF_Science @criscancer
Honored to receive the Michael O. Koch Award for Early Career Scholars at the Indiana University GU Cancer Symposium!
A huge thank you to @ClintCaryMD and @asmaakenawy for the invitation to present my work in the #BeltranLab. It was a privilege to meet Dr. Michael Koch himself!
I really enjoyed co-mentoring Arianny Mordan this summer, a talented student from the Workforce Development Program @DanaFarber. She gifted me a mug, but Iβm too embarrassed to use it!
Excited to see all youβll accomplish, Arianny!
Thanks to @mishabeltran for the support.
Thank you for the invitation to present, @PathfinderDFHCC!
Excited to discuss our recent work published in @CR_AACR at this 'micro' journal club where I'll summarize the paper in < 10 min, followed by a discussion.
Open to all. Register if interested!
@mishabeltran @DanaFarber_GU
This Post is from an account that no longer exists. Learn more


































